Cargando…

Fabry disease: a survey of visual and ocular symptoms

PURPOSE: To evaluate a visual symptoms survey on patients with a known diagnosis of Fabry disease, and to compare the scores to those from a group of healthy subjects. MATERIALS AND METHODS: An ocular symptom survey instrument was used to evaluate the symptoms of general ocular problems like itching...

Descripción completa

Detalles Bibliográficos
Autor principal:	Davey, Pinakin Gunvant
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145731/ https://www.ncbi.nlm.nih.gov/pubmed/25170250 http://dx.doi.org/10.2147/OPTH.S66748

Ejemplares similares

Macular pigment optical density: repeatability, intereye correlation, and effect of ocular dominance
por: Davey, Pinakin Gunvant, et al.
Publicado: (2016)

The Effect of Zeaxanthin on the Visual Acuity of Zebrafish
por: Saidi, Eric A., et al.
Publicado: (2015)

Relationships between central corneal thickness and optic disc topography in eyes with glaucoma, suspicion of glaucoma, or ocular hypertension
por: Gunvant, Pinakin, et al.
Publicado: (2008)

Efficacy of Commercially Available Nutritional Supplements: Analysis of Serum Uptake, Macular Pigment Optical Density and Visual Functional Response
por: Bone, Richard A., et al.
Publicado: (2020)

Intraeye retinal nerve fiber layer and macular thickness asymmetry measurements for the discrimination of primary open-angle glaucoma and normal tension glaucoma
por: Khanal, Safal, et al.
Publicado: (2016)

Differences in macular pigment optical density across four ethnicities: a comparative study
por: Davey, Pinakin Gunvant, et al.
Publicado: (2020)

A Systematic Review of Carotenoids in the Management of Diabetic Retinopathy
por: Lem, Drake W., et al.
Publicado: (2021)

Carotenoids in the Management of Glaucoma: A Systematic Review of the Evidence
por: Lem, Drake W., et al.
Publicado: (2021)

Can Nutrition Play a Role in Ameliorating Digital Eye Strain?
por: Lem, Drake W., et al.
Publicado: (2022)

Predicting the necessity of LASIK enhancement after cataract surgery in patients with multifocal IOL implantation
por: Gunvant, Pinakin, et al.
Publicado: (2011)

Macular Pigment Reflectometry: Developing Clinical Protocols, Comparison with Heterochromatic Flicker Photometry and Individual Carotenoid Levels
por: Davey, Pinakin Gunvant, et al.
Publicado: (2021)

Physiologic anisocoria under various lighting conditions
por: Steck, Ryan P, et al.
Publicado: (2018)

Ocular findings in Fabry disease in Colombian patients
por: Rothstein, Katherine, et al.
Publicado: (2019)

Investigation of ocular involvement in patients with Fabry disease
por: Wu, Yuan, et al.
Publicado: (2023)

Visual Function and Macular Carotenoid Changes in Eyes with Retinal Drusen—An Open Label Randomized Controlled Trial to Compare a Micronized Lipid-Based Carotenoid Liquid Supplementation and AREDS-2 Formula
por: Davey, Pinakin Gunvant, et al.
Publicado: (2020)

Prevalence of symptoms in female Fabry disease patients: a case-control survey
por: Bouwman, Machtelt G., et al.
Publicado: (2012)

Symptoms and Quality of Life in Patients with Fabry Disease: Results from an International Patient Survey
por: Morand, Olivier, et al.
Publicado: (2019)

A Systematic Review of Carotenoids in the Management of Age-Related Macular Degeneration
por: Lem, Drake W., et al.
Publicado: (2021)

The development of a reference database with the Topcon 3D OCT-1 Maestro
por: Chaglasian, Michael, et al.
Publicado: (2018)

Gastrointestinal Symptoms of Patients with Fabry Disease
por: Pensabene, Licia, et al.
Publicado: (2016)

Ocular Signs Correlate Well with Disease Severity and Genotype in Fabry Disease
por: Pitz, Susanne, et al.
Publicado: (2015)

Paediatric Fabry disease: prognostic significance of ocular changes for disease severity
por: Kalkum, Gisela, et al.
Publicado: (2016)

Ocular manifestations in a patient with de novo Fabry disease
por: Lee, You Hyun, et al.
Publicado: (2018)

Longitudinal study on ocular manifestations in a cohort of patients with Fabry disease
por: Michaud, Langis
Publicado: (2019)

Correlation of retinal vascular characteristics with laboratory and ocular findings in Fabry disease: exploring ocular diagnostic biomarkers
por: Lindziute, Migle, et al.
Publicado: (2023)

Autophagy-lysosome pathway alteration in ocular surface manifestations in Fabry disease patients
por: Marenco, Marco, et al.
Publicado: (2022)

Predicting individual contrast sensitivity functions from acuity and letter contrast sensitivity measurements
por: Thurman, Steven M., et al.
Publicado: (2016)

Multicenter Female Fabry Study (MFFS) - clinical survey on current treatment of females with Fabry disease
por: Lenders, Malte, et al.
Publicado: (2016)

Genetic variants associated with gastrointestinal symptoms in Fabry disease
por: Di Martino, Maria Teresa, et al.
Publicado: (2016)

Characteristics of Neurological Symptoms in Adult Japanese Patients with Fabry Disease
por: Sawada, Jun, et al.
Publicado: (2021)

Rats deficient in α-galactosidase A develop ocular manifestations of Fabry disease
por: Miller, James J., et al.
Publicado: (2019)

A survey on the patient journey in Fabry disease in Japan
por: Tsurumi, Mina, et al.
Publicado: (2022)

Development of the Fabry Disease Patient-Reported Outcome (FD-PRO): a new instrument to measure the symptoms and impacts of Fabry Disease
por: Hamed, Alaa, et al.
Publicado: (2021)

Parkinson's disease prevalence in Fabry disease: A survey study
por: Wise, Adina H., et al.
Publicado: (2017)

Night Vision and Carotenoids (NVC): A Randomized Placebo Controlled Clinical Trial on Effects of Carotenoid Supplementation on Night Vision in Older Adults
por: Richer, Stuart, et al.
Publicado: (2021)

Reply to Green-Gomez et al. Comment on “Richer et al. Night Vision and Carotenoids (NVC): A Randomized Placebo Controlled Clinical Trial on Effects of Carotenoid Supplementation on Night Vision in Older Adults. Nutrients 2021, 13, 3191”
por: Richer, Stuart, et al.
Publicado: (2022)

Fabry Disease Patient-Reported Outcome (FD-PRO) demonstrates robust measurement properties for assessing symptom severity in Fabry disease
por: Hamed, Alaa, et al.
Publicado: (2021)

Cognitive functioning and depressive symptoms in Fabry disease: A follow‐up study
por: Körver, Simon, et al.
Publicado: (2020)

Excessive Daytime Sleepiness Is a Common Symptom in Fabry Disease
por: Duning, Thomas, et al.
Publicado: (2009)

Long-term effectiveness of agalsidase alfa enzyme replacement in Fabry disease: A Fabry Outcome Survey analysis
por: Beck, Michael, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_995b93d27s4n49trru52sl0b8g